PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1987 February; 79(2): 637–642.
PMCID: PMC424152

Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma.

Abstract

To investigate the relationship of the lymphoid hyperplasia of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) to supervening malignant lymphoma, we subjected DNA from lymph nodes and peripheral blood mononuclear cells from five AILD patients to Southern blot analysis to detect clonal rearrangements of immunoglobulin and T-cell receptor genes. Lymph nodes and peripheral blood from AILD patients were found to contain clones of lymphoid cells harboring either immunoglobulin or T-cell receptor gene rearrangements that, in some instances, regressed during the course of disease. A lymph node from one patient was involved by immunoblastic lymphoma and manifested an additional gene rearrangement pattern not seen in premalignant specimens from that patient. In contrast, DNA obtained from normal peripheral blood mononuclear cells and 11 examples of other forms of lymphoid hyperplasia showed no gene rearrangements. As a disorder of cellular immunoregulation in which lymphoid cells may escape normal growth controls, AILD provides a natural model to dissect stages of lymphomagenesis in man.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet. 1974 Jun 1;1(7866):1070–1073. [PubMed]
  • Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med. 1975 Dec;59(6):803–818. [PubMed]
  • Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med. 1975 Jan 2;292(1):1–8. [PubMed]
  • Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer. 1978 Feb;41(2):578–606. [PubMed]
  • Pangalis GA, Moran EM, Nathwani BN, Zelman RJ, Kim H, Rappaport H. Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer. 1983 Jul 15;52(2):318–321. [PubMed]
  • Rudders RA, DeLellis R. Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol. 1977 Oct;68(4):518–521. [PubMed]
  • Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H. Evolution of immunoblastic lymphoma in angioimmunoblastic lymphadenopathy. Recent Results Cancer Res. 1978;64:235–240. [PubMed]
  • Klajman A, Yaretzky A, Schneider M, Holoshitz Y, Shneur A, Griffel B. Angioimmunoblastic lymphadenopathy with paraproteinemia: a T- and B-cell disorder. Cancer. 1981 Dec 1;48(11):2433–2437. [PubMed]
  • Mazur EM, Lovett DH, Enriquez RE, Breg WR, Jr, Papac RJ. Angioimmunoblastic lymphadenopathy evolution to a Burkitt-like lymphoma. Am J Med. 1979 Aug;67(2):317–324. [PubMed]
  • Boros L, Bhaskar AG, D'Souza JP. Monoclonal evolution of angioimmunoblastic lymphadenopathy. Am J Clin Pathol. 1981 Jun;75(6):856–860. [PubMed]
  • Greer JP, York JC, Cousar JB, Mitchell RT, Flexner JM, Collins RD, Stein RS. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol. 1984 Jul;2(7):788–798. [PubMed]
  • Kaneko Y, Larson RA, Variakojis D, Haren JM, Rowley JD. Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. Blood. 1982 Oct;60(4):877–887. [PubMed]
  • Korsmeyer SJ, Arnold A, Bakhshi A, Ravetch JV, Siebenlist U, Hieter PA, Sharrow SO, LeBien TW, Kersey JH, Poplack DG, et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983 Feb;71(2):301–313. [PMC free article] [PubMed]
  • Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983 Dec 29;309(26):1593–1599. [PubMed]
  • Cleary ML, Chao J, Warnke R, Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A. 1984 Jan;81(2):593–597. [PubMed]
  • Flug F, Pelicci PG, Bonetti F, Knowles DM, 2nd, Dalla-Favera R. T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms. Proc Natl Acad Sci U S A. 1985 May;82(10):3460–3464. [PubMed]
  • Aisenberg AC, Krontiris TG, Mak TW, Wilkes BM. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med. 1985 Aug 29;313(9):529–533. [PubMed]
  • Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA., Jr T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29;313(9):534–538. [PubMed]
  • Weiss LM, Hu E, Wood GS, Moulds C, Cleary ML, Warnke R, Sklar J. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med. 1985 Aug 29;313(9):539–544. [PubMed]
  • Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
  • Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. [PubMed]
  • Toyonaga B, Yanagi Y, Suciu-Foca N, Minden M, Mak TW. Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones. Nature. 311(5984):385–387. [PubMed]
  • Pelicci PG, Knowles DM, 2nd, Dalla Favera R. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. J Exp Med. 1985 Sep 1;162(3):1015–1024. [PMC free article] [PubMed]
  • Waldmann TA, Davis MM, Bongiovanni KF, Korsmeyer SJ. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. N Engl J Med. 1985 Sep 26;313(13):776–783. [PubMed]
  • Flandrin G. Angioimmunoblastic lymphadenopathy: clinical, biologic, and follow-up study of 14 cases. Recent Results Cancer Res. 1978;64:247–262. [PubMed]
  • Lapes MJ, Vivacqua RJ, Antoniades K. Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin). Lancet. 1976 Jan 24;1(7952):198–198. [PubMed]
  • Weisenburger DD. Immunoblastic lymphadenopathy associated with methyldopa therapy: a case report. Cancer. 1978 Nov;42(5):2322–2327. [PubMed]
  • Honda M, Smith HR, Steinberg AD. Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest. 1985 Jul;76(1):332–340. [PMC free article] [PubMed]
  • Rowley JD. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 1984 Aug;44(8):3159–3168. [PubMed]
  • Mountz JD, Steinberg AD, Klinman DM, Smith HR, Mushinski JF. Autoimmunity and increased c-myb transcription. Science. 1984 Nov 30;226(4678):1087–1089. [PubMed]
  • Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A. 1979 May;76(5):2442–2446. [PubMed]
  • Croce CM, Tsujimoto Y, Erikson J, Nowell P. Chromosome translocations and B cell neoplasia. Lab Invest. 1984 Sep;51(3):258–267. [PubMed]
  • Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet FC, et al. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med. 1985 May 2;312(18):1151–1159. [PubMed]
  • Cleary ML, Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet. 1984 Sep 1;2(8401):489–493. [PubMed]
  • Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW, Jr, Hardesty RL, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984 Mar 17;1(8377):583–587. [PMC free article] [PubMed]
  • Korsmeyer SJ, Greene WC, Cossman J, Hsu SM, Jensen JP, Neckers LM, Marshall SL, Bakhshi A, Depper JM, Leonard WJ, et al. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522–4526. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation